Fact Sheet

Model-Based Meta-Analysis (MBMA): Real-World Examples

See real-world examples of how model-based meta-analysis (MBMA) uses existing clinical evidence to predict trial…

CertaraAugust 24, 2026

Webinar

How to Choose Your First-in-Human Dose Approach

CertaraAugust 17, 2026

Blog

MBMA data curation: How AI and expert meta-analysts get it right, fast

In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…

Matt Zierhut, PhD MBAAugust 14, 2026

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhDAugust 13, 2026

Webinar

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

CertaraAugust 6, 2026

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

CertaraJuly 29, 2026

Blog

Important drug development questions that model-based meta-analysis answers

Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…

Matt Zierhut, PhD MBAJuly 23, 2026

Conference

EANM 2026

–

Danielle PillsburyJuly 20, 2026

Webinar

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhDJuly 17, 2026

Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

CertaraJuly 13, 2026

Certara Services

Model-Based Meta-Analysis (MBMA): Real-World Examples

How to Choose Your First-in-Human Dose Approach

MBMA data curation: How AI and expert meta-analysts get it right, fast

A model-informed approach to radioligand therapy dosing under Project Optimus

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Important drug development questions that model-based meta-analysis answers

EANM 2026

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

Newsletter sign up

Quick links

Solutions

Contact